Optogenetics on FDSS7000EX: Light-stimulated membrane depolarization in cultured cells expressing channelrhodopsin using a kinetic plate reader
Poster Feb 14, 2017
Sunao Hisada1, Taira Ito1, Natsumi Kato1, Hirohumi Horai1, Shouming Du2, Masanori Matsubara1 and Mitsu Saito3
Channelrhodopsin (ChR), an algal protein from Chlamydomonas reinhardtti, is a light-activated cation channel capable of inducing membrane depolarization and can trigger action potentials when it is expressed in excitable cells. Coupling of such optogentic tools with fluorescent-based high-throughput screening (HTS) assays is expected to play a major role in the neural and cardiovascular drug discovery and development. In this study, we incorporated the blue-light stimulation capability to the FDSS 7000EX kinetic plate reader to establish the optogenetic-membrane potential dye assay system.
We developed clonal cell lines that stably express ChR2WR (a chimeric protein of channelrhodopsin 1 and 2; ChR2WR) and ChR2WR with a human voltage-dependent sodium channel (NaV1.5), and a human inward rectifier potassium channel (KCNJ2).
Our optogenetic-membrane potential dye assays using the FDSS 7000EX kinetic plate reader revealed that Depolarization initiated by light-(480 nm) induced ChR2WR activation resulted in Lidocaine-sensitive membrane depolarization. Also responses to 20 repetitive light stimuli were all captured by the FDSS 7000EX plate reader suggesting its applicability for use dependent drug screening. Our report suggests that fluorescence measurements using the FDSS 7000EX kinetic plate reader when it is combined with optogenetic is a useful tool for the HTS.
Assessment of Oral LISPRO Treatment in Ameliorating Amyloid and Tau Pathology in Transgenic Alzheimer’s Mice ModelPoster
Ionic co-crystals of lithium salicylate with organic proline (LISPRO) showed better safety and pharmacokinetic profile of lithium in plasma and brain of wild-type and transgenic Alzheimer mice model compared to lithium salts.READ MORE
Combining a Real-Time In Vitro Cell Viability Assay and RNA Extraction from the Same 3D SpheroidsPoster
We report here the results of using a novel small molecule probe that viable cells convert into a substrate for a shrimp-derived luciferase to generate a signal proportional to the number of viable cells.READ MORE
CiPA Phase 2 Study: validation of an automated microelectrode array (MEA) assay of hiPSC-derived cardiomyocyte electrophysiology for cardiac safety evaluationPoster
These results support the use of hSC-CM and MEA technology for preclinical assessment of proarrhythmic risk within the proposed CiPA paradigm, and, more generally, demonstrate that automation of the CM-MEA assay can achieve high reliability and throughput for cardiac risk assessment in vitro.READ MORE
Comments | 0 ADD COMMENT
Outsourcing in Clinical Trials Southern California
Sep 27 - Sep 28, 2017